Category
Primary
biotech-and-biomedical-industry · embed-ft 0.45
Tree path
Business and Finance › Industries › Biotech and Biomedical Industry
Group (tier-1)
Also (top-3)
Tech stack
AI readiness
Compliance (GEO / GDPR)
TLD
Overview
Title
Biokine Therapeutics – A New Horizon For Cancer Therapy
Description
Targeting Migration, Survival and Immune-response Pathways In cancer The Biokine Story Biokine Therapeutics is a private biopharmaceutical company founded in 2000. Biokine lead product BKT140/BL8040, is a high affinity, long-acting CXCR4 receptor inhibitor that already passed successful Phase III for Stem Cell Mobilization and Phase I/II for Immunotherapy for cancer together
Final URL
Language
en (html)
Scanned at
2026-06-19 14:58:43